nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0264	0.0376	CbGbCtD
Venlafaxine—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.026	0.0371	CbGbCtD
Venlafaxine—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0245	0.0348	CbGbCtD
Venlafaxine—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0245	0.0348	CbGbCtD
Venlafaxine—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.0239	0.034	CbGbCtD
Venlafaxine—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.0239	0.034	CbGbCtD
Venlafaxine—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0229	0.0326	CbGbCtD
Venlafaxine—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0221	0.0315	CbGbCtD
Venlafaxine—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0186	0.0264	CbGbCtD
Venlafaxine—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.0177	0.0252	CbGbCtD
Venlafaxine—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0168	0.0239	CbGbCtD
Venlafaxine—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0165	0.0236	CbGbCtD
Venlafaxine—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0156	0.0221	CbGbCtD
Venlafaxine—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0141	0.02	CbGbCtD
Venlafaxine—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0141	0.02	CbGbCtD
Venlafaxine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0138	0.0196	CbGbCtD
Venlafaxine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0129	0.0184	CbGbCtD
Venlafaxine—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0129	0.0184	CbGbCtD
Venlafaxine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0126	0.0179	CbGbCtD
Venlafaxine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0126	0.0179	CbGbCtD
Venlafaxine—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0121	0.0173	CbGbCtD
Venlafaxine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0118	0.0168	CbGbCtD
Venlafaxine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0118	0.0168	CbGbCtD
Venlafaxine—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0118	0.0168	CbGbCtD
Venlafaxine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0117	0.0166	CbGbCtD
Venlafaxine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0117	0.0166	CbGbCtD
Venlafaxine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0114	0.0162	CbGbCtD
Venlafaxine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0107	0.0152	CbGbCtD
Venlafaxine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0107	0.0152	CbGbCtD
Venlafaxine—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0107	0.0152	CbGbCtD
Venlafaxine—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0107	0.0152	CbGbCtD
Venlafaxine—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0102	0.0146	CbGbCtD
Venlafaxine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0101	0.0144	CbGbCtD
Venlafaxine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0098	0.014	CbGbCtD
Venlafaxine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0098	0.0139	CbGbCtD
Venlafaxine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00951	0.0135	CbGbCtD
Venlafaxine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00923	0.0131	CbGbCtD
Venlafaxine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00896	0.0128	CbGbCtD
Venlafaxine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00886	0.0126	CbGbCtD
Venlafaxine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00886	0.0126	CbGbCtD
Venlafaxine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0086	0.0122	CbGbCtD
Venlafaxine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0086	0.0122	CbGbCtD
Venlafaxine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0085	0.0121	CbGbCtD
Venlafaxine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00825	0.0117	CbGbCtD
Venlafaxine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00811	0.0115	CbGbCtD
Venlafaxine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00811	0.0115	CbGbCtD
Venlafaxine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.008	0.0114	CbGbCtD
Venlafaxine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00752	0.0107	CbGbCtD
Venlafaxine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00752	0.0107	CbGbCtD
Venlafaxine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0068	0.00968	CbGbCtD
Venlafaxine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0068	0.00968	CbGbCtD
Venlafaxine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00638	0.00908	CbGbCtD
Venlafaxine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00587	0.00836	CbGbCtD
Venlafaxine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0057	0.00811	CbGbCtD
Venlafaxine—NPY1R—nerve—acquired immunodeficiency syndrome	0.00515	0.12	CbGeAlD
Venlafaxine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00515	0.00734	CbGbCtD
Venlafaxine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00515	0.00734	CbGbCtD
Venlafaxine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00494	0.00703	CbGbCtD
Venlafaxine—SLC6A3—nerve—acquired immunodeficiency syndrome	0.00217	0.0504	CbGeAlD
Venlafaxine—SLC6A2—nerve—acquired immunodeficiency syndrome	0.00175	0.0407	CbGeAlD
Venlafaxine—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.0015	0.035	CbGeAlD
Venlafaxine—NPY1R—blood—acquired immunodeficiency syndrome	0.00143	0.0332	CbGeAlD
Venlafaxine—NPY1R—vagina—acquired immunodeficiency syndrome	0.00132	0.0308	CbGeAlD
Venlafaxine—NPY1R—lung—acquired immunodeficiency syndrome	0.00125	0.0291	CbGeAlD
Venlafaxine—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00125	0.029	CbGeAlD
Venlafaxine—NPY1R—nervous system—acquired immunodeficiency syndrome	0.00116	0.027	CbGeAlD
Venlafaxine—NPY1R—central nervous system—acquired immunodeficiency syndrome	0.00112	0.026	CbGeAlD
Venlafaxine—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000975	0.0227	CbGeAlD
Venlafaxine—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000966	0.0225	CbGeAlD
Venlafaxine—NPY1R—brain—acquired immunodeficiency syndrome	0.000886	0.0206	CbGeAlD
Venlafaxine—NPY1R—lymph node—acquired immunodeficiency syndrome	0.000856	0.0199	CbGeAlD
Venlafaxine—NPY1R—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.000856	0.0678	CbGpPWpGaD
Venlafaxine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000736	0.0171	CbGeAlD
Venlafaxine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000725	0.0168	CbGeAlD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.000664	0.0526	CbGpPWpGaD
Venlafaxine—SLC6A3—spinal cord—acquired immunodeficiency syndrome	0.000579	0.0135	CbGeAlD
Venlafaxine—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.000578	0.0134	CbGeAlD
Venlafaxine—SLC6A4—blood—acquired immunodeficiency syndrome	0.000551	0.0128	CbGeAlD
Venlafaxine—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.000531	0.0123	CbGeAlD
Venlafaxine—SLC6A3—lung—acquired immunodeficiency syndrome	0.000527	0.0123	CbGeAlD
Venlafaxine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000521	0.0121	CbGeAlD
Venlafaxine—SLC6A3—nervous system—acquired immunodeficiency syndrome	0.000488	0.0113	CbGeAlD
Venlafaxine—SLC6A4—lung—acquired immunodeficiency syndrome	0.000483	0.0112	CbGeAlD
Venlafaxine—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000479	0.0111	CbGeAlD
Venlafaxine—NPY1R—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.000478	0.0379	CbGpPWpGaD
Venlafaxine—SLC6A3—central nervous system—acquired immunodeficiency syndrome	0.00047	0.0109	CbGeAlD
Venlafaxine—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000469	0.0109	CbGeAlD
Venlafaxine—CYP2C19—blood—acquired immunodeficiency syndrome	0.000456	0.0106	CbGeAlD
Venlafaxine—NPY1R—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.00045	0.0356	CbGpPWpGaD
Venlafaxine—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000447	0.0104	CbGeAlD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000446	0.0353	CbGpPWpGaD
Venlafaxine—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.00043	0.01	CbGeAlD
Venlafaxine—SLC6A2—lung—acquired immunodeficiency syndrome	0.000425	0.00988	CbGeAlD
Venlafaxine—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000423	0.00984	CbGeAlD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.000403	0.0319	CbGpPWpGaD
Venlafaxine—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.000394	0.00915	CbGeAlD
Venlafaxine—ABCG2—blood—acquired immunodeficiency syndrome	0.000387	0.009	CbGeAlD
Venlafaxine—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.00038	0.00883	CbGeAlD
Venlafaxine—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.000379	0.00881	CbGeAlD
Venlafaxine—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000375	0.00872	CbGeAlD
Venlafaxine—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000375	0.00871	CbGeAlD
Venlafaxine—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000373	0.00868	CbGeAlD
Venlafaxine—SLC6A3—brain—acquired immunodeficiency syndrome	0.000373	0.00867	CbGeAlD
Venlafaxine—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000371	0.00863	CbGeAlD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.000364	0.0288	CbGpPWpGaD
Venlafaxine—ABCG2—vagina—acquired immunodeficiency syndrome	0.000359	0.00835	CbGeAlD
Venlafaxine—CYP2B6—blood—acquired immunodeficiency syndrome	0.000357	0.00831	CbGeAlD
Venlafaxine—CYP2C9—blood—acquired immunodeficiency syndrome	0.000354	0.00823	CbGeAlD
Venlafaxine—SLC6A4—brain—acquired immunodeficiency syndrome	0.000342	0.00795	CbGeAlD
Venlafaxine—ABCG2—lung—acquired immunodeficiency syndrome	0.000339	0.00789	CbGeAlD
Venlafaxine—NPY1R—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000339	0.0269	CbGpPWpGaD
Venlafaxine—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000331	0.0077	CbGeAlD
Venlafaxine—SLC6A4—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.000328	0.026	CbGpPWpGaD
Venlafaxine—CYP2B6—lung—acquired immunodeficiency syndrome	0.000313	0.00728	CbGeAlD
Venlafaxine—NPY1R—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.000308	0.0244	CbGpPWpGaD
Venlafaxine—SLC6A2—brain—acquired immunodeficiency syndrome	0.000301	0.007	CbGeAlD
Venlafaxine—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.000291	0.00676	CbGeAlD
Venlafaxine—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.00029	0.00674	CbGeAlD
Venlafaxine—ABCB1—retina—acquired immunodeficiency syndrome	0.000285	0.00664	CbGeAlD
Venlafaxine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000283	0.00658	CbGeAlD
Venlafaxine—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000279	0.00649	CbGeAlD
Venlafaxine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000279	0.00648	CbGeAlD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00027	0.0214	CbGpPWpGaD
Venlafaxine—CYP3A4—blood—acquired immunodeficiency syndrome	0.00027	0.00627	CbGeAlD
Venlafaxine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000265	0.00617	CbGeAlD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000249	0.0197	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000244	0.0193	CbGpPWpGaD
Venlafaxine—ABCG2—brain—acquired immunodeficiency syndrome	0.00024	0.00559	CbGeAlD
Venlafaxine—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000232	0.0054	CbGeAlD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000225	0.0178	CbGpPWpGaD
Venlafaxine—CYP2B6—brain—acquired immunodeficiency syndrome	0.000222	0.00515	CbGeAlD
Venlafaxine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000219	0.00509	CbGeAlD
Venlafaxine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000215	0.00501	CbGeAlD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000211	0.0167	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000211	0.0167	CbGpPWpGaD
Venlafaxine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000211	0.0049	CbGeAlD
Venlafaxine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000207	0.00482	CbGeAlD
Venlafaxine—NPY1R—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000206	0.0163	CbGpPWpGaD
Venlafaxine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000203	0.00472	CbGeAlD
Venlafaxine—ABCB1—digestive system—acquired immunodeficiency syndrome	0.0002	0.00466	CbGeAlD
Venlafaxine—ABCB1—blood—acquired immunodeficiency syndrome	0.000191	0.00444	CbGeAlD
Venlafaxine—NPY1R—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.00019	0.015	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000186	0.0147	CbGpPWpGaD
Venlafaxine—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000185	0.0043	CbGeAlD
Venlafaxine—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000184	0.00428	CbGeAlD
Venlafaxine—NPY1R—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000178	0.0141	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000178	0.0141	CbGpPWpGaD
Venlafaxine—ABCB1—vagina—acquired immunodeficiency syndrome	0.000177	0.00412	CbGeAlD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000176	0.0139	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000174	0.0138	CbGpPWpGaD
Venlafaxine—ABCB1—lung—acquired immunodeficiency syndrome	0.000167	0.00389	CbGeAlD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000167	0.0132	CbGpPWpGaD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000166	0.0131	CbGpPWpGaD
Venlafaxine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000165	0.00383	CbGeAlD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000161	0.0127	CbGpPWpGaD
Venlafaxine—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000155	0.0036	CbGeAlD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000151	0.0119	CbGpPWpGaD
Venlafaxine—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000149	0.00347	CbGeAlD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000145	0.0115	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000142	0.0112	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000142	0.0112	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000136	0.0107	CbGpPWpGaD
Venlafaxine—ABCG2—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	0.000135	0.0107	CbGpPWpGaD
Venlafaxine—ABCG2—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	0.000135	0.0107	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000127	0.0101	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000122	0.00968	CbGpPWpGaD
Venlafaxine—ABCB1—brain—acquired immunodeficiency syndrome	0.000118	0.00276	CbGeAlD
Venlafaxine—NPY1R—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000115	0.0091	CbGpPWpGaD
Venlafaxine—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000114	0.00266	CbGeAlD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000113	0.00899	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000108	0.00855	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000108	0.00855	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000108	0.00855	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000106	0.00836	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000103	0.00815	CbGpPWpGaD
Venlafaxine—SLC6A4—Monoamine Transport—TNF—acquired immunodeficiency syndrome	9.94e-05	0.00787	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	9.72e-05	0.0077	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	9.54e-05	0.00756	CbGpPWpGaD
Venlafaxine—SLC6A2—Monoamine Transport—TNF—acquired immunodeficiency syndrome	8.55e-05	0.00677	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	8.22e-05	0.00651	CbGpPWpGaD
Venlafaxine—SLC6A3—Monoamine Transport—TNF—acquired immunodeficiency syndrome	7.57e-05	0.006	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	7.4e-05	0.00586	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	7.35e-05	0.00582	CbGpPWpGaD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	7.31e-05	0.00579	CbGpPWpGaD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	7.31e-05	0.00579	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	6.52e-05	0.00516	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	6.49e-05	0.00514	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	6.33e-05	0.00501	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	6.23e-05	0.00494	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	6.23e-05	0.00494	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	6.1e-05	0.00483	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	6.1e-05	0.00483	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	5.9e-05	0.00467	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	5.64e-05	0.00446	CbGpPWpGaD
Venlafaxine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	5.59e-05	0.000231	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	5.59e-05	0.000231	CcSEcCtD
Venlafaxine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	5.58e-05	0.000231	CcSEcCtD
Venlafaxine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	5.57e-05	0.00023	CcSEcCtD
Venlafaxine—Pruritus—Stavudine—acquired immunodeficiency syndrome	5.56e-05	0.00023	CcSEcCtD
Venlafaxine—Asthenia—Abacavir—acquired immunodeficiency syndrome	5.56e-05	0.00023	CcSEcCtD
Venlafaxine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	5.55e-05	0.00023	CcSEcCtD
Venlafaxine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	5.55e-05	0.000229	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	5.54e-05	0.00439	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	5.54e-05	0.00439	CbGpPWpGaD
Venlafaxine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	5.54e-05	0.000229	CcSEcCtD
Venlafaxine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	5.54e-05	0.000229	CcSEcCtD
Venlafaxine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	5.54e-05	0.000229	CcSEcCtD
Venlafaxine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	5.52e-05	0.000228	CcSEcCtD
Venlafaxine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	5.52e-05	0.000228	CcSEcCtD
Venlafaxine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	5.52e-05	0.000228	CcSEcCtD
Venlafaxine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	5.51e-05	0.000228	CcSEcCtD
Venlafaxine—Pruritus—Abacavir—acquired immunodeficiency syndrome	5.48e-05	0.000227	CcSEcCtD
Venlafaxine—Fatigue—Indinavir—acquired immunodeficiency syndrome	5.48e-05	0.000227	CcSEcCtD
Venlafaxine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	5.48e-05	0.000226	CcSEcCtD
Venlafaxine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	5.48e-05	0.000226	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	5.47e-05	0.000226	CcSEcCtD
Venlafaxine—Cough—Saquinavir—acquired immunodeficiency syndrome	5.47e-05	0.000226	CcSEcCtD
Venlafaxine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	5.46e-05	0.000226	CcSEcCtD
Venlafaxine—Pain—Indinavir—acquired immunodeficiency syndrome	5.43e-05	0.000225	CcSEcCtD
Venlafaxine—Constipation—Indinavir—acquired immunodeficiency syndrome	5.43e-05	0.000225	CcSEcCtD
Venlafaxine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	5.43e-05	0.000225	CcSEcCtD
Venlafaxine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	5.43e-05	0.000224	CcSEcCtD
Venlafaxine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	5.43e-05	0.000224	CcSEcCtD
Venlafaxine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	5.42e-05	0.000224	CcSEcCtD
Venlafaxine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	5.41e-05	0.000224	CcSEcCtD
Venlafaxine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	5.4e-05	0.000223	CcSEcCtD
Venlafaxine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	5.4e-05	0.000223	CcSEcCtD
Venlafaxine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	5.4e-05	0.000223	CcSEcCtD
Venlafaxine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	5.39e-05	0.000223	CcSEcCtD
Venlafaxine—Malaise—Lamivudine—acquired immunodeficiency syndrome	5.39e-05	0.000223	CcSEcCtD
Venlafaxine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	5.38e-05	0.000222	CcSEcCtD
Venlafaxine—Nausea—Didanosine—acquired immunodeficiency syndrome	5.38e-05	0.000222	CcSEcCtD
Venlafaxine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	5.37e-05	0.000222	CcSEcCtD
Venlafaxine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	5.37e-05	0.000222	CcSEcCtD
Venlafaxine—Syncope—Lamivudine—acquired immunodeficiency syndrome	5.36e-05	0.000222	CcSEcCtD
Venlafaxine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	5.36e-05	0.000222	CcSEcCtD
Venlafaxine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	5.35e-05	0.000221	CcSEcCtD
Venlafaxine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	5.35e-05	0.000221	CcSEcCtD
Venlafaxine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	5.34e-05	0.000221	CcSEcCtD
Venlafaxine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	5.33e-05	0.000221	CcSEcCtD
Venlafaxine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	5.33e-05	0.000221	CcSEcCtD
Venlafaxine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	5.33e-05	0.000221	CcSEcCtD
Venlafaxine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	5.32e-05	0.00022	CcSEcCtD
Venlafaxine—Oedema—Ritonavir—acquired immunodeficiency syndrome	5.31e-05	0.00022	CcSEcCtD
Venlafaxine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	5.3e-05	0.000219	CcSEcCtD
Venlafaxine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	5.29e-05	0.000219	CcSEcCtD
Venlafaxine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	5.27e-05	0.000218	CcSEcCtD
Venlafaxine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	5.25e-05	0.000217	CcSEcCtD
Venlafaxine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	5.24e-05	0.000217	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	5.23e-05	0.000216	CcSEcCtD
Venlafaxine—Shock—Ritonavir—acquired immunodeficiency syndrome	5.23e-05	0.000216	CcSEcCtD
Venlafaxine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	5.22e-05	0.000216	CcSEcCtD
Venlafaxine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	5.22e-05	0.000216	CcSEcCtD
Venlafaxine—Cough—Lamivudine—acquired immunodeficiency syndrome	5.22e-05	0.000216	CcSEcCtD
Venlafaxine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	5.21e-05	0.000216	CcSEcCtD
Venlafaxine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	5.2e-05	0.000215	CcSEcCtD
Venlafaxine—Dizziness—Stavudine—acquired immunodeficiency syndrome	5.2e-05	0.000215	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	5.2e-05	0.000215	CcSEcCtD
Venlafaxine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	5.2e-05	0.000215	CcSEcCtD
Venlafaxine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	5.18e-05	0.000214	CcSEcCtD
Venlafaxine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	5.18e-05	0.000214	CcSEcCtD
Venlafaxine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	5.18e-05	0.000214	CcSEcCtD
Venlafaxine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	5.18e-05	0.000214	CcSEcCtD
Venlafaxine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	5.16e-05	0.000213	CcSEcCtD
Venlafaxine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	5.16e-05	0.000213	CcSEcCtD
Venlafaxine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	5.14e-05	0.000212	CcSEcCtD
Venlafaxine—Pain—Efavirenz—acquired immunodeficiency syndrome	5.13e-05	0.000212	CcSEcCtD
Venlafaxine—Constipation—Efavirenz—acquired immunodeficiency syndrome	5.13e-05	0.000212	CcSEcCtD
Venlafaxine—Rash—Nevirapine—acquired immunodeficiency syndrome	5.13e-05	0.000212	CcSEcCtD
Venlafaxine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	5.13e-05	0.000212	CcSEcCtD
Venlafaxine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	5.12e-05	0.000212	CcSEcCtD
Venlafaxine—Dizziness—Abacavir—acquired immunodeficiency syndrome	5.12e-05	0.000212	CcSEcCtD
Venlafaxine—Oedema—Saquinavir—acquired immunodeficiency syndrome	5.11e-05	0.000211	CcSEcCtD
Venlafaxine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	5.11e-05	0.000211	CcSEcCtD
Venlafaxine—Headache—Nevirapine—acquired immunodeficiency syndrome	5.1e-05	0.000211	CcSEcCtD
Venlafaxine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	5.09e-05	0.00021	CcSEcCtD
Venlafaxine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	5.09e-05	0.00021	CcSEcCtD
Venlafaxine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	5.09e-05	0.00021	CcSEcCtD
Venlafaxine—Infection—Saquinavir—acquired immunodeficiency syndrome	5.08e-05	0.00021	CcSEcCtD
Venlafaxine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	5.07e-05	0.00021	CcSEcCtD
Venlafaxine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	5.06e-05	0.000209	CcSEcCtD
Venlafaxine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	5.06e-05	0.000209	CcSEcCtD
Venlafaxine—Urticaria—Indinavir—acquired immunodeficiency syndrome	5.05e-05	0.000209	CcSEcCtD
Venlafaxine—Shock—Saquinavir—acquired immunodeficiency syndrome	5.03e-05	0.000208	CcSEcCtD
Venlafaxine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	5.03e-05	0.000208	CcSEcCtD
Venlafaxine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	5.02e-05	0.000208	CcSEcCtD
Venlafaxine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	5.02e-05	0.000208	CcSEcCtD
Venlafaxine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	5.01e-05	0.000207	CcSEcCtD
Venlafaxine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	5.01e-05	0.000207	CcSEcCtD
Venlafaxine—Vomiting—Stavudine—acquired immunodeficiency syndrome	5e-05	0.000207	CcSEcCtD
Venlafaxine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	4.99e-05	0.000207	CcSEcCtD
Venlafaxine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	4.98e-05	0.000206	CcSEcCtD
Venlafaxine—Rash—Nelfinavir—acquired immunodeficiency syndrome	4.97e-05	0.000206	CcSEcCtD
Venlafaxine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	4.97e-05	0.000205	CcSEcCtD
Venlafaxine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	4.96e-05	0.000205	CcSEcCtD
Venlafaxine—Rash—Stavudine—acquired immunodeficiency syndrome	4.96e-05	0.000205	CcSEcCtD
Venlafaxine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	4.95e-05	0.000205	CcSEcCtD
Venlafaxine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	4.95e-05	0.000205	CcSEcCtD
Venlafaxine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	4.95e-05	0.000205	CcSEcCtD
Venlafaxine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	4.94e-05	0.000204	CcSEcCtD
Venlafaxine—Headache—Nelfinavir—acquired immunodeficiency syndrome	4.94e-05	0.000204	CcSEcCtD
Venlafaxine—Headache—Stavudine—acquired immunodeficiency syndrome	4.92e-05	0.000204	CcSEcCtD
Venlafaxine—Vomiting—Abacavir—acquired immunodeficiency syndrome	4.92e-05	0.000204	CcSEcCtD
Venlafaxine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	4.92e-05	0.000203	CcSEcCtD
Venlafaxine—Constipation—Delavirdine—acquired immunodeficiency syndrome	4.91e-05	0.000203	CcSEcCtD
Venlafaxine—Pain—Delavirdine—acquired immunodeficiency syndrome	4.91e-05	0.000203	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	4.91e-05	0.000203	CcSEcCtD
Venlafaxine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	4.9e-05	0.000203	CcSEcCtD
Venlafaxine—Rash—Abacavir—acquired immunodeficiency syndrome	4.88e-05	0.000202	CcSEcCtD
Venlafaxine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	4.88e-05	0.000202	CcSEcCtD
Venlafaxine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	4.88e-05	0.000202	CcSEcCtD
Venlafaxine—Oedema—Lamivudine—acquired immunodeficiency syndrome	4.88e-05	0.000202	CcSEcCtD
Venlafaxine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	4.87e-05	0.000202	CcSEcCtD
Venlafaxine—Headache—Abacavir—acquired immunodeficiency syndrome	4.85e-05	0.000201	CcSEcCtD
Venlafaxine—Infection—Lamivudine—acquired immunodeficiency syndrome	4.85e-05	0.0002	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	4.84e-05	0.0002	CcSEcCtD
Venlafaxine—Nausea—Nevirapine—acquired immunodeficiency syndrome	4.84e-05	0.0002	CcSEcCtD
Venlafaxine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	4.83e-05	0.0002	CcSEcCtD
Venlafaxine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	4.8e-05	0.000199	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	4.8e-05	0.0038	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	4.8e-05	0.0038	CbGpPWpGaD
Venlafaxine—Shock—Lamivudine—acquired immunodeficiency syndrome	4.8e-05	0.000198	CcSEcCtD
Venlafaxine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	4.78e-05	0.000198	CcSEcCtD
Venlafaxine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	4.78e-05	0.000197	CcSEcCtD
Venlafaxine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	4.77e-05	0.000197	CcSEcCtD
Venlafaxine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	4.77e-05	0.000197	CcSEcCtD
Venlafaxine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	4.75e-05	0.000196	CcSEcCtD
Venlafaxine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	4.75e-05	0.000196	CcSEcCtD
Venlafaxine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	4.74e-05	0.000196	CcSEcCtD
Venlafaxine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	4.73e-05	0.000196	CcSEcCtD
Venlafaxine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	4.72e-05	0.000195	CcSEcCtD
Venlafaxine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	4.72e-05	0.000195	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	4.7e-05	0.000194	CcSEcCtD
Venlafaxine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	4.68e-05	0.000194	CcSEcCtD
Venlafaxine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	4.68e-05	0.000194	CcSEcCtD
Venlafaxine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	4.68e-05	0.000193	CcSEcCtD
Venlafaxine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	4.68e-05	0.000193	CcSEcCtD
Venlafaxine—Nausea—Stavudine—acquired immunodeficiency syndrome	4.67e-05	0.000193	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	4.67e-05	0.0037	CbGpPWpGaD
Venlafaxine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	4.66e-05	0.000193	CcSEcCtD
Venlafaxine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	4.65e-05	0.000192	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.64e-05	0.00368	CbGpPWpGaD
Venlafaxine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	4.62e-05	0.000191	CcSEcCtD
Venlafaxine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	4.62e-05	0.000191	CcSEcCtD
Venlafaxine—Nausea—Abacavir—acquired immunodeficiency syndrome	4.6e-05	0.00019	CcSEcCtD
Venlafaxine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	4.59e-05	0.00019	CcSEcCtD
Venlafaxine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	4.58e-05	0.000189	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.57e-05	0.00362	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	4.56e-05	0.00361	CbGpPWpGaD
Venlafaxine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	4.56e-05	0.000189	CcSEcCtD
Venlafaxine—Asthenia—Indinavir—acquired immunodeficiency syndrome	4.56e-05	0.000189	CcSEcCtD
Venlafaxine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	4.56e-05	0.000189	CcSEcCtD
Venlafaxine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	4.56e-05	0.000188	CcSEcCtD
Venlafaxine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	4.55e-05	0.000188	CcSEcCtD
Venlafaxine—Pain—Ritonavir—acquired immunodeficiency syndrome	4.54e-05	0.000188	CcSEcCtD
Venlafaxine—Constipation—Ritonavir—acquired immunodeficiency syndrome	4.54e-05	0.000188	CcSEcCtD
Venlafaxine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	4.54e-05	0.000188	CcSEcCtD
Venlafaxine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	4.54e-05	0.000188	CcSEcCtD
Venlafaxine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	4.52e-05	0.000187	CcSEcCtD
Venlafaxine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	4.5e-05	0.000186	CcSEcCtD
Venlafaxine—Pruritus—Indinavir—acquired immunodeficiency syndrome	4.5e-05	0.000186	CcSEcCtD
Venlafaxine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	4.44e-05	0.000184	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	4.44e-05	0.000184	CcSEcCtD
Venlafaxine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	4.42e-05	0.000183	CcSEcCtD
Venlafaxine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	4.41e-05	0.000182	CcSEcCtD
Venlafaxine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	4.41e-05	0.000182	CcSEcCtD
Venlafaxine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	4.38e-05	0.000181	CcSEcCtD
Venlafaxine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	4.38e-05	0.000181	CcSEcCtD
Venlafaxine—Pain—Saquinavir—acquired immunodeficiency syndrome	4.37e-05	0.000181	CcSEcCtD
Venlafaxine—Constipation—Saquinavir—acquired immunodeficiency syndrome	4.37e-05	0.000181	CcSEcCtD
Venlafaxine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	4.35e-05	0.00018	CcSEcCtD
Venlafaxine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	4.35e-05	0.00018	CcSEcCtD
Venlafaxine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	4.34e-05	0.00018	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	4.34e-05	0.00018	CcSEcCtD
Venlafaxine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	4.34e-05	0.000179	CcSEcCtD
Venlafaxine—Rash—Zidovudine—acquired immunodeficiency syndrome	4.31e-05	0.000178	CcSEcCtD
Venlafaxine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	4.31e-05	0.000178	CcSEcCtD
Venlafaxine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	4.3e-05	0.000178	CcSEcCtD
Venlafaxine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	4.29e-05	0.000178	CcSEcCtD
Venlafaxine—Headache—Zidovudine—acquired immunodeficiency syndrome	4.28e-05	0.000177	CcSEcCtD
Venlafaxine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	4.25e-05	0.000176	CcSEcCtD
Venlafaxine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	4.24e-05	0.000175	CcSEcCtD
Venlafaxine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	4.23e-05	0.000175	CcSEcCtD
Venlafaxine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	4.22e-05	0.000175	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.22e-05	0.00334	CbGpPWpGaD
Venlafaxine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	4.21e-05	0.000174	CcSEcCtD
Venlafaxine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	4.21e-05	0.000174	CcSEcCtD
Venlafaxine—Dizziness—Indinavir—acquired immunodeficiency syndrome	4.2e-05	0.000174	CcSEcCtD
Venlafaxine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	4.2e-05	0.000174	CcSEcCtD
Venlafaxine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	4.2e-05	0.000174	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.18e-05	0.00331	CbGpPWpGaD
Venlafaxine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	4.18e-05	0.000173	CcSEcCtD
Venlafaxine—Constipation—Lamivudine—acquired immunodeficiency syndrome	4.17e-05	0.000172	CcSEcCtD
Venlafaxine—Pain—Lamivudine—acquired immunodeficiency syndrome	4.17e-05	0.000172	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.15e-05	0.00329	CbGpPWpGaD
Venlafaxine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	4.12e-05	0.00017	CcSEcCtD
Venlafaxine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	4.11e-05	0.00017	CcSEcCtD
Venlafaxine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	4.06e-05	0.000168	CcSEcCtD
Venlafaxine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	4.06e-05	0.000168	CcSEcCtD
Venlafaxine—Nausea—Zidovudine—acquired immunodeficiency syndrome	4.06e-05	0.000168	CcSEcCtD
Venlafaxine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	4.04e-05	0.000167	CcSEcCtD
Venlafaxine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	4.04e-05	0.000167	CcSEcCtD
Venlafaxine—Vomiting—Indinavir—acquired immunodeficiency syndrome	4.04e-05	0.000167	CcSEcCtD
Venlafaxine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	4.02e-05	0.000166	CcSEcCtD
Venlafaxine—Rash—Indinavir—acquired immunodeficiency syndrome	4.01e-05	0.000166	CcSEcCtD
Venlafaxine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	4e-05	0.000166	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	3.99e-05	0.000165	CcSEcCtD
Venlafaxine—Headache—Indinavir—acquired immunodeficiency syndrome	3.98e-05	0.000165	CcSEcCtD
Venlafaxine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	3.97e-05	0.000164	CcSEcCtD
Venlafaxine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	3.93e-05	0.000163	CcSEcCtD
Venlafaxine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	3.91e-05	0.000162	CcSEcCtD
Venlafaxine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	3.88e-05	0.00016	CcSEcCtD
Venlafaxine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	3.86e-05	0.000159	CcSEcCtD
Venlafaxine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	3.86e-05	0.000159	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.85e-05	0.00305	CbGpPWpGaD
Venlafaxine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	3.82e-05	0.000158	CcSEcCtD
Venlafaxine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	3.81e-05	0.000158	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.8e-05	0.00301	CbGpPWpGaD
Venlafaxine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	3.8e-05	0.000157	CcSEcCtD
Venlafaxine—Rash—Efavirenz—acquired immunodeficiency syndrome	3.79e-05	0.000157	CcSEcCtD
Venlafaxine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	3.78e-05	0.000156	CcSEcCtD
Venlafaxine—Nausea—Indinavir—acquired immunodeficiency syndrome	3.77e-05	0.000156	CcSEcCtD
Venlafaxine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	3.77e-05	0.000156	CcSEcCtD
Venlafaxine—Headache—Efavirenz—acquired immunodeficiency syndrome	3.76e-05	0.000156	CcSEcCtD
Venlafaxine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	3.76e-05	0.000155	CcSEcCtD
Venlafaxine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	3.67e-05	0.000152	CcSEcCtD
Venlafaxine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	3.65e-05	0.000151	CcSEcCtD
Venlafaxine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	3.63e-05	0.00015	CcSEcCtD
Venlafaxine—Rash—Delavirdine—acquired immunodeficiency syndrome	3.62e-05	0.00015	CcSEcCtD
Venlafaxine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	3.62e-05	0.00015	CcSEcCtD
Venlafaxine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	3.62e-05	0.00015	CcSEcCtD
Venlafaxine—Headache—Delavirdine—acquired immunodeficiency syndrome	3.6e-05	0.000149	CcSEcCtD
Venlafaxine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	3.59e-05	0.000149	CcSEcCtD
Venlafaxine—Nausea—Efavirenz—acquired immunodeficiency syndrome	3.57e-05	0.000147	CcSEcCtD
Venlafaxine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	3.51e-05	0.000145	CcSEcCtD
Venlafaxine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	3.5e-05	0.000145	CcSEcCtD
Venlafaxine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	3.5e-05	0.000145	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.48e-05	0.00276	CbGpPWpGaD
Venlafaxine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	3.45e-05	0.000143	CcSEcCtD
Venlafaxine—Nausea—Delavirdine—acquired immunodeficiency syndrome	3.41e-05	0.000141	CcSEcCtD
Venlafaxine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	3.38e-05	0.00014	CcSEcCtD
Venlafaxine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	3.38e-05	0.00014	CcSEcCtD
Venlafaxine—Rash—Ritonavir—acquired immunodeficiency syndrome	3.35e-05	0.000139	CcSEcCtD
Venlafaxine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	3.35e-05	0.000138	CcSEcCtD
Venlafaxine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	3.34e-05	0.000138	CcSEcCtD
Venlafaxine—Headache—Ritonavir—acquired immunodeficiency syndrome	3.33e-05	0.000138	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.27e-05	0.00259	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.27e-05	0.00259	CbGpPWpGaD
Venlafaxine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	3.25e-05	0.000134	CcSEcCtD
Venlafaxine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	3.23e-05	0.000133	CcSEcCtD
Venlafaxine—Rash—Saquinavir—acquired immunodeficiency syndrome	3.22e-05	0.000133	CcSEcCtD
Venlafaxine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	3.22e-05	0.000133	CcSEcCtD
Venlafaxine—Headache—Saquinavir—acquired immunodeficiency syndrome	3.2e-05	0.000132	CcSEcCtD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.18e-05	0.00252	CbGpPWpGaD
Venlafaxine—Nausea—Ritonavir—acquired immunodeficiency syndrome	3.16e-05	0.00013	CcSEcCtD
Venlafaxine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	3.1e-05	0.000128	CcSEcCtD
Venlafaxine—Rash—Lamivudine—acquired immunodeficiency syndrome	3.08e-05	0.000127	CcSEcCtD
Venlafaxine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	3.07e-05	0.000127	CcSEcCtD
Venlafaxine—Headache—Lamivudine—acquired immunodeficiency syndrome	3.06e-05	0.000126	CcSEcCtD
Venlafaxine—Nausea—Saquinavir—acquired immunodeficiency syndrome	3.04e-05	0.000126	CcSEcCtD
Venlafaxine—ABCG2—Metabolism—TAT—acquired immunodeficiency syndrome	3.01e-05	0.00238	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	2.9e-05	0.0023	CbGpPWpGaD
Venlafaxine—Nausea—Lamivudine—acquired immunodeficiency syndrome	2.9e-05	0.00012	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	2.82e-05	0.00223	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	2.8e-05	0.00222	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.71e-05	0.00214	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.56e-05	0.00203	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	2.51e-05	0.00199	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.49e-05	0.00197	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.45e-05	0.00194	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.42e-05	0.00191	CbGpPWpGaD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.4e-05	0.0019	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	2.26e-05	0.00179	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.24e-05	0.00178	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—TAT—acquired immunodeficiency syndrome	2.21e-05	0.00175	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.2e-05	0.00174	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—AGPS—acquired immunodeficiency syndrome	1.88e-05	0.00149	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	1.84e-05	0.00146	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	1.83e-05	0.00145	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—TAT—acquired immunodeficiency syndrome	1.67e-05	0.00132	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	1.63e-05	0.00129	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	1.53e-05	0.00121	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	1.52e-05	0.0012	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—AGPS—acquired immunodeficiency syndrome	1.42e-05	0.00112	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.38e-05	0.0011	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.38e-05	0.00109	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	1.3e-05	0.00103	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.3e-05	0.00103	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	1.29e-05	0.00102	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.29e-05	0.00102	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.22e-05	0.000965	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.12e-05	0.000888	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1e-05	0.000794	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	9.01e-06	0.000714	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	8.53e-06	0.000675	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.62e-06	0.000604	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	6.53e-06	0.000517	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.06e-06	0.00048	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	5.95e-06	0.000471	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ALB—acquired immunodeficiency syndrome	5.25e-06	0.000416	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ALB—acquired immunodeficiency syndrome	3.85e-06	0.000305	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	2.91e-06	0.00023	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	2.84e-06	0.000225	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	2.67e-06	0.000212	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	2.65e-06	0.00021	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	1.75e-06	0.000138	CbGpPWpGaD
